450 research outputs found

    Alien Registration- Sevigny, J. Leo (Mexico, Oxford County)

    Get PDF
    https://digitalmaine.com/alien_docs/18006/thumbnail.jp

    A Return to Manning the Post: the Adaptive Reuse of Publically Owned Fire Control Stations from the Second World War

    Get PDF
    This project examines the adaptive reuse potential of World War II-era fire control stations situated on public lands. The goal was to show the economic feasibility of reusing these derelict structures while simultaneously raising awareness of the scarce resources from our nation’s recent past. This has been done by conducting existing conditions assessments, forming scopes of work, attaining cost estimates, and creating cost analyses on three individual stations within two case studies in the northeastern United States. The cost analyses were based on Donovan Rypkema’s pro forma spreadsheet templates from the Feasibility Assessment Manual for Reusing Historic Buildings. Through this process, these abandoned stations showed potential to become a valuable income-generating asset for the public agency in ownership of these structures while saving a valuable piece of our World War II home front heritage

    The Development of Electroconvulsive Therapy

    Get PDF
    The current acceptance of electroconvulsive therapy (ECT) as a suitable treatment for depression is a result of years of medical and ethical controversy. The treatment faced social, political, and scientific barriers as it developed; however, its effectiveness in treating mental disorders has allowed it to remain in use to this day. This paper will trace the changes electroconvulsive therapy has seen in technology, application, and societal endorsement over the years

    Marshall system for aerospace simulation (MARSYAS)

    Get PDF
    System is simple flexible language which can be coded by users unfamiliar with computer programming. It is designed for engineers with little experience in simulation, who desire to simulate large physical systems. User has ability to mix differential equations with diagrams in his model. With few exceptions, there is no rigid statement-operator structure within given module

    Preliminary Technology Maturation Plan for Immobilization of High-Level Waste in Glass Ceramics

    Get PDF
    A technology maturation plan (TMP) was developed for immobilization of high-level waste (HLW) raffinate in a glass ceramics waste form using a cold-crucible induction melter (CCIM). The TMP was prepared by the following process: 1) define the reference process and boundaries of the technology being matured, 2) evaluate the technology elements and identify the critical technology elements (CTE), 3) identify the technology readiness level (TRL) of each of the CTE’s using the DOE G 413.3-4, 4) describe the development and demonstration activities required to advance the TRLs to 4 and 6 in order, and 5) prepare a preliminary plan to conduct the development and demonstration. Results of the technology readiness assessment identified five CTE’s and found relatively low TRL’s for each of them: • Mixing, sampling, and analysis of waste slurry and melter feed: TRL-1 • Feeding, melting, and pouring: TRL-1 • Glass ceramic formulation: TRL-1 • Canister cooling and crystallization: TRL-1 • Canister decontamination: TRL-4 Although the TRL’s are low for most of these CTE’s (TRL-1), the effort required to advance them to higher values. The activities required to advance the TRL’s are listed below: • Complete this TMP • Perform a preliminary engineering study • Characterize, estimate, and simulate waste to be treated • Laboratory scale glass ceramic testing • Melter and off-gas testing with simulants • Test the mixing, sampling, and analyses • Canister testing • Decontamination system testing • Issue a requirements document • Issue a risk management document • Complete preliminary design • Integrated pilot testing • Issue a waste compliance plan A preliminary schedule and budget were developed to complete these activities as summarized in the following table (assuming 2012 dollars). TRL Budget Year MSA FMP GCF CCC CD Overall $M 2012 1 1 1 1 4 1 0.3 2013 2 2 1 1 4 1 1.3 2014 2 3 1 1 4 1 1.8 2015 2 3 2 2 4 2 2.6 2016 2 3 2 2 4 2 4.9 2017 2 3 3 2 4 2 9.8 2018 3 3 3 3 4 3 7.9 2019 3 3 3 3 4 3 5.1 2020 3 3 3 3 4 3 14.6 2021 3 3 3 3 4 3 7.3 2022 3 3 3 3 4 3 8.8 2023 4 4 4 4 4 4 9.1 2024 5 5 5 5 5 5 6.9 2025 6 6 6 6 6 6 6.9 CCC = canister cooling and crystallization; FMP = feeding, melting, and pouring; GCF = glass ceramic formulation; MSA = mixing, sampling, and analyses. This TMP is intended to guide the development of the glass ceramics waste form and process to the point where it is ready for industrialization

    Identification of a Human Monoclonal Antibody to Replace Equine Diphtheria Anti-toxin for the Treatment of Diphtheria

    Get PDF
    Diphtheria anti-toxin (DAT) has been used to treat Corynebacterium diphtheriae infection for over one hundred years. While the global incidence of diphtheria has declined in the 20th century, the disease remains endemic in many parts of the world and significant outbreaks still occur. Diphtheria anti-toxin is an equine polyclonal antibody with considerable side effects that is in critically short supply globally. A safer, more readily available alternative to DAT would be desirable. In the current study, we cloned human monoclonal antibodies (HuMabs) directly from antibody secreting cells of human volunteers immunized with Td vaccine. We isolated a diverse panel of HuMabs that recognized diphtheria toxoid and recombinant protein fragments of diphtheria toxin. Forty-one unique HuMabs were expressed in 293T cells and tested for neutralization of diphtheria toxin in in vitro cytotoxicity assays. The lead candidate HuMab, 315C4 potently neutralized diphtheria toxin with an EC50 of 0.65 ng/mL. Additionally, 25 μg of 315C4 completely protected guinea pigs in an in vivo lethality model. In comparison, 1.6 IU of DAT was necessary for full protection resulting in an estimated relative potency of 64 IU/mg for 315C4. We further established that our lead candidate HuMab binds to the receptor binding domain of diphtheria toxin and blocks the toxin from binding to the putative receptor, heparin binding-epidermal growth factor like growth factor. The discovery of a specific and potent neutralizing antibody against diphtheria toxin holds promise as a potential human therapeutic and is being developed for human use
    • …
    corecore